Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -1.51% vs -0.80% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 100.85% vs -82.25% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 20.18% vs -33.69% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -11.78% vs 63.68% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Yixintang Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -13.23% vs 8.66% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -1.51% vs -0.80% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -42.54% vs 183.66% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 100.85% vs -82.25% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -15.02% vs 105.82% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 20.18% vs -33.69% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -5.85% vs -7.07% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -11.78% vs 63.68% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






